Medexus Pharmaceuticals Inc. ( MEDXF) - Stock Earnings
MEDXF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -441110 USD | 34.6 million USD |
| 2025Q4 | — USD | 34.4 million USD |
| 2026Q1 | — USD | 35.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MEDXF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 808430 USD | 154.4 million USD |
| 2025 | 6.9 million USD | 149.0 million USD |
| 2026 | — USD | 141.0 million USD |
| 2026 Est. | — | — |
MEDXF
Price: $3.39
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -114.50
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 105.7 million